Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | CO3.2K |
| Molecular Weight | 138.2055 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[K+].[K+].[O-]C([O-])=O
InChI
InChIKey=BWHMMNNQKKPAPP-UHFFFAOYSA-L
InChI=1S/CH2O3.2K/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2
| Molecular Formula | K |
| Molecular Weight | 39.0983 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | CO3 |
| Molecular Weight | 60.0089 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Potash (Dihydroxyaluminum Sodium Carbonate), a component of
Kompensan-S Forte in Germany, is a basic inorganic salt that acts by neutralizing hydrochloric acid in gastric secretions. Kompensan-S Forte is slowly solubilized in the stomach and reacts with hydrochloric acid to form aluminum chloride and water. It also inhibits the action of pepsin by increasing the pH and via adsorption. Cytoprotective effects may occur through increases in bicarbonate ion (HCO3-) and prostaglandins.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL261 |
|||
Target ID: CHEMBL205 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Kompensan Approved UseGastrointestinal disorders: Dyspepsia, Duodenal Ulcer, Erosive Esophagitis, Gastric Ulcer, Gastroesophageal Reflux Disease, Zollinger-Ellison Syndrome, Hyperphosphatemia |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Automation of dihydroxyaluminum sodium carbonate analysis in antacid tablets by energy dispersive X-ray fluorescence. | 1990 May-Jun |
|
| Effect of pepsin on the kinetics of HCl neutralization by dihydroxyaluminum sodium carbonate, hydrotalcite and dihydroxyaluminum aminoacetate. | 1991 |
Sample Use Guides
Usual Adult Dose for Dyspepsia: 500 to 600 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Duodenal Ulcer: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Erosive Esophagitis: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Gastric Ulcer: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Gastroesophageal Reflux Disease: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Zollinger-Ellison Syndrome: 500 to 3600 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Hyperphosphatemia: 500 to 1000 mg orally 4 times a day, with meals and at bedtime. The dosage should be titrated to the serum phosphate level.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:54:33 GMT 2023
by
admin
on
Fri Dec 15 15:54:33 GMT 2023
|
| Record UNII |
BQN1B9B9HA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
JECFA EVALUATION |
INS-501(I)
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
||
|
CFR |
21 CFR 184.1619
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-501(I)
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
||
|
EPA PESTICIDE CODE |
73504
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
||
|
DSLD |
3764 (Number of products:1)
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
||
|
CFR |
21 CFR 331.15
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
||
|
CFR |
21 CFR 331.11
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
584-08-7
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
BQN1B9B9HA
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
11430
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107967
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
100000079172
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
C037593
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
SUB14971MIG
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
m9010
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | Merck Index | ||
|
POTASSIUM CARBONATE
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
DTXSID2036245
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
1262
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
DB13977
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
C84095
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
CONCEPT | Industrial Aid | ||
|
34300
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
BQN1B9B9HA
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
1548167
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY | |||
|
209-529-3
Created by
admin on Fri Dec 15 15:54:33 GMT 2023 , Edited by admin on Fri Dec 15 15:54:33 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SUB_CONCEPT->SUBSTANCE | |||
|
SOLVATE->ANHYDROUS |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
